These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7543270)

  • 21. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion.
    Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S
    Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiamine disulfide as a potent inhibitor of human immunodeficiency virus (type-1) production.
    Shoji S; Furuishi K; Misumi S; Miyazaki T; Kino M; Yamataka K
    Biochem Biophys Res Commun; 1994 Nov; 205(1):967-75. PubMed ID: 7999140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.
    Ojwang JO; Buckheit RW; Pommier Y; Mazumder A; De Vreese K; Esté JA; Reymen D; Pallansch LA; Lackman-Smith C; Wallace TL
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2426-35. PubMed ID: 8585721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of triciribine and triciribine-5'-monophosphate against human immunodeficiency virus types 1 and 2.
    Kucera LS; Iyer NP; Puckett SH; Buckheit RW; Westbrook L; Toyer BR; White EL; Germany-Decker JM; Shannon WM; Chen RC
    AIDS Res Hum Retroviruses; 1993 Apr; 9(4):307-14. PubMed ID: 7685612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.
    Stein CA; Pal R; DeVico AL; Hoke G; Mumbauer S; Kinstler O; Sarngadharan MG; Letsinger RL
    Biochemistry; 1991 Mar; 30(9):2439-44. PubMed ID: 1705817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutralization of HIV-1 and inhibition of HIV-1-induced syncytia by 1,8-naphthalimide photoactive compound.
    Chanh TC; Lewis DE; Allan JS; Sogandares-Bernal F; Judy MM; Utecht RE; Matthews JL
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):891-6. PubMed ID: 8257636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4.
    Stein CA; Neckers LM; Nair BC; Mumbauer S; Hoke G; Pal R
    J Acquir Immune Defic Syndr (1988); 1991; 4(7):686-93. PubMed ID: 1711118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
    Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
    Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MAP 30: a new inhibitor of HIV-1 infection and replication.
    Lee-Huang S; Huang PL; Nara PL; Chen HC; Kung HF; Huang P; Huang HI; Huang PL
    FEBS Lett; 1990 Oct; 272(1-2):12-8. PubMed ID: 1699801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides.
    Andreola ML; Calmels C; Michel J; Toulmé JJ; Litvak S
    Eur J Biochem; 2000 Aug; 267(16):5032-40. PubMed ID: 10931185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of human immunodeficiency virus production and cytopathic effects by inhibitors of the Na+/K+/2Cl- cotransporter.
    Voss TG; Gatti PJ; Fermin CD; Garry RF
    Virology; 1996 May; 219(1):291-4. PubMed ID: 8623543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of inhibition of HIV-1 infection in vitro by guanine-rich oligonucleotides modified at the 5' terminal by dimethoxytrityl residue.
    Furukawa H; Momota K; Agatsuma T; Yamamoto I; Kimura S; Shimada K
    Nucleic Acids Res; 1994 Dec; 22(25):5621-7. PubMed ID: 7530843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro.
    Pal R; Mumbauer S; Hoke G; Larocca R; Myers C; Sarngadharan MG; Stein CA
    AIDS Res Hum Retroviruses; 1991 Jun; 7(6):537-43. PubMed ID: 1718343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-cycloserine, an inhibitor of sphingolipid biosynthesis, inhibits HIV-1 cytopathic effects, replication, and infectivity.
    Mizrachi Y; Lev M; Harish Z; Sundaram SK; Rubinstein A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Feb; 11(2):137-41. PubMed ID: 8556395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture.
    Letsinger RL; Zhang GR; Sun DK; Ikeuchi T; Sarin PS
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6553-6. PubMed ID: 2771942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction.
    Bader JP; McMahon JB; Schultz RJ; Narayanan VL; Pierce JB; Harrison WA; Weislow OS; Midelfort CF; Stinson SF; Boyd MR
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6740-4. PubMed ID: 1713689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine.
    Ojwang J; Elbaggari A; Marshall HB; Jayaraman K; McGrath MS; Rando RF
    J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):560-70. PubMed ID: 7513761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.
    Baba M; Tanaka H; De Clercq E; Pauwels R; Balzarini J; Schols D; Nakashima H; Perno CF; Walker RT; Miyasaka T
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1375-81. PubMed ID: 2575380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
    Konopka K; Pretzer E; Düzgünes N
    Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives.
    Pauwels R; Andries K; Desmyter J; Schols D; Kukla MJ; Breslin HJ; Raeymaeckers A; Van Gelder J; Woestenborghs R; Heykants J
    Nature; 1990 Feb; 343(6257):470-4. PubMed ID: 1689015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.